TABLE 1.
Summary of demographic and clinical data
| Item | TLE | HC | p‐Value |
|---|---|---|---|
| Number (F/M) | 66 (38/28) | 31 (15/16) | .529 a |
| Age | 30.43 (9.92) | 33.87 (10.03) | .117 b |
| Education | 10.98 (3.19) | 12.66 (4.29) | .042 c |
| Verbal memory z‐score | −1.27 (1.47) | 0 | <.0001 c |
| Nonverbal memory z‐score | −0.80 (0.99) | 0 | .001 c |
| TLE‐MD | TLE‐MI | ||
| Number (F/M) | 31 (14/17) | 35 (24/11) | .054 a |
| Age | 32.84 (10.53) | 28.31 (8.97) | .067 b |
| Education | 9.71 (2.93) | 12.11 (3.02) | .002 c |
| Side, L/R | 19/12 | 17/18 | .300 a |
| Age at onset | 17.06 (10.47) | 15.00 (8.30) | .384 b |
| Duration | 16.52 (10.06) | 13.80 (8.30) | .266 b |
| Seizure frequency per month | 9.24 (22.94) | 13.61 (31.17) | .827 c |
| Numbers of AED | 2.19 (0.79) | 2.2 (0.90) | .847 c |
| Patients on carbamazepine | 15 (45.2%) | 11 (31.4%) | .159 a |
| Patients on topiramate | 3 (3.2%) | 1 (5.7%) | .335 d |
| Verbal memory z‐score | −2.42 (1.02) | −0.18 (0.84) | <.0001 c |
| Nonverbal memory z‐score | −1.37 (0.92) | −0.22 (0.72) | <.0001 c |
Note: SDs are presented in parentheses.
Abbreviations: AED, antiepileptic drug; MD, memory deficit; MI, memory intact; TLE, temporal lobe epilepsy.
a
p‐Value was obtained by Pearson chi‐square test.
b
p‐Value were obtained by Student's t test.
c
p‐Value were obtained by Mann–Whitney test.
d
p‐Value were obtained by Fisher exact test.